Clinical Trials
2 trialsNCT01162135 2025-05-04
Digoxin for Recurrent Prostate Cancer
Thomas Jefferson University
Phase 2 Completed
NCT04094519 2024-11-20
A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancer
Astellas Pharma Inc
Phase 1 Completed